Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Author Archives: Warren Woessner
Indefiniteness After Nautilus – A Very “Delicate Balance”
In Interval Lighting v. AOL, Inc., Appeal no. 2013-1282, -1283, -1284, -1285 (Fed. Cir. Sept. 10, 2014), the appealed indefiniteness finding by the district court was affirmed by the Fed. Cir. panel. This was not surprising, since the disputed term … Continue reading
Posted in Patenting Methods/Processes
Tagged AOL, Enzo Biochem, Federal Circuit, Interval Lighting, Patent Law, Warren Woessner
2 Comments
Australia: Cancer Voices v Myriad Opinion Affirmed
This is a guest post from Paul Cole. An opinion was handed down earlier today by the Federal Court of Australia – Full Court (Allsop C.J., Downsett, Kenny, Bennett and Middleton J.J., D’Arcy v Myriad Genetics Inc [2014] FCAFC 115 … Continue reading
Posted in EP and UK Practice
Tagged biotechnology law, EPO, intellectual property, ip, Myriad, Patent Law, patents, Paul Cole, Warren Woessner
2 Comments
101 Rejections Under the Guidelines: Mayo and Myriad “Go Viral”
This is a guest post from Hans Sauer, Deputy General Counsel, Intellectual Property for BIO. “Recently, I set out to find real-world examples of recent rejections under the USPTO Guidance, to do my own sampling rather than rely on reported … Continue reading
Posted in Claim Interpretation
Tagged bio, biotechnology law, biotechnology news, Federal Circuit, Hans Sauer, intellectual property, ip, Mayo, Myriad, Patent Law, patents, USPTO, Warren Woessner
1 Comment
BIO IP & Diagnostics Symposium
Warren Woessner will be moderating a panel on university-industry (from start-ups to big pharma) partnering in the area of companion diagnostics and personalized medicine at the BIO IP and Diagnostics Symposium, September 26th at the Alexandria Hilton. Since the first two … Continue reading